AYALA PHARMACEUTICAL

AYLA
Delayed Quote. Delayed  - 10/20 04:00:00 pm
9.4USD -2.10%

Turn to zoom
Prev.9.6019
Open9.5700
High10.3200
Low9.3700
Volume7 842
Latest news
09/23
09/23
09/16
09/16
Chart AYALA PHARMACEUTICALS, INC.
Financials
Sales 2021 3,52 M - -
Net income 2021 -41,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,17x
Yield 2021 -
Capitalization 123 M 123 M -
Capi. / Sales 2021 35,0x
Capi. / Sales 2022 34,2x
Nbr of Employees 34
Free-Float 45,3%
Company
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company. The Company is focused on developing and commercializing small molecule therapeutics for patients suffering from rare cancers. The Company's portfolio of product candidates includes, AL101 and AL102, which targets the aberrant...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-23 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 9,40 $
Average target price 22,33 $
Spread / Average Target 138%